CEO of Onyx Pharmaceuticals on the Future of Drug Development
Forbes Healthcare Summit 2012
Dec 21, 2012
| Business of Medicine
N. Anthony Coles, MD
, President and CEO of Onyx Pharmaceuticals
, discusses how developments in genomics and personalized medicine can pave the way for the future of drug development.
This interview was conducted at the Forbes Healthcare Summit 2012.
Read more about N. Anthony Coles.